Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
11 /100
LOW RISK
Score updated Aug 28, 2026

TGTX — TG Therapeutics, Inc. Dilution Risk Tracker

Track TGTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TGTX — Get alerts when the score changes →

As of August 28, 2026, TG Therapeutics, Inc. (TGTX) has a DilutionWatch DilutionScore of 11/100, rated LOW dilution risk. TG Therapeutics, Inc. has a market capitalization of $5.81B, 153.07M shares outstanding, 368 institutional holders tracked. Stored dilution-related fields include 147.1K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
12
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for TGTX.
🔔 Track TGTX — Get forecast alerts →

Market Data

Market Cap$5.81B
Shares Outstanding153.07M
Float135.10M
Cash$552.25M
Debt$745.39M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 19.2% shares (2026Q1 vs prior)
368 institutional holders · 129.97M shares
#1 BlackRock, Inc. 22.25M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 13.21M shares
#3 STATE STREET CORP 8.65M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest29.32M
Days to Cover13.6
% of Float21.7%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2023-12-31
xbrl XBRL WARRANT 2023-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual TGTX Dilution Snapshot

TG Therapeutics, Inc. (TGTX) has a DilutionScore of 11/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track TGTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TGTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TGTX
TGTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.